Pulmonary Embolism Short-term Clinical Outcomes Registry

Completed

Conditions studied: Pulmonary Embolism

In brief

The overall goal of this clinical research study is to prospectively assess primary outcomes related to pulmonary embolism (PE) that occur immediately (within 5 days) and within 30 days. The secondary goal is to compare validated prediction models and a modified European Society of Cardiology (ESC) approach that is primarily right ventricle dysfunction (RVD) driven with clinical risk assessment being secondary, and with primary outcomes of clinical deterioration within 5 days.

Key facts

Study ID

NCT02883491

Run by

Wake Forest University Health Sciences

People needed

815

Starts

2016-08-01

Expected to finish

2019-02-20

Last updated by the study team

2022-04-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years or older with image confirmed acute pulmonary embolism diagnosed within 12 hours of ED presentation will be eligible for enrollment.

You may not qualify if…

• Patients who refuse consent for 30-day clinical contact and follow-up.

Where it is running

• San Diego Medical Center — San Diego, California, United States
• Christiana Care Health System — Newark, Delaware, United States
• Orlando Regional Medical Center — Orlando, Florida, United States
• Carolinas Healthcare System — Charlotte, North Carolina, United States
• Vanderbilt Medical Center — Nashville, Tennessee, United States
• University of Utah Hospital — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.